MBK Partners is seeking a buyer for Techpack Solutions Co. Ltd., a South Korean bottler, according to Reuters. The deal could be worth up to $565 million. www.techpacksol.com

Wind Point Partners has hired Barclays to find a buyer for Hearthside Food Solutions, a Downers Grove, Ill.–based food contract manufacturer, according to Reuters. The deal could be worth more than $1 billion, with Hearthside reportedly generating $120 million in EBITDA. www.hearthsidefoods.com

AMC Networks Inc. (Nasdaq: AMCX) has agreed to acquire Chellomedia, the international content division of Liberty Global (Nasdaq:LBTYA), for €750 million. The deal is expected to close in Q1 2014. www.amcnetworks.com

NTT Communications Corp. (Tokyo: 9432) has agreed to acquire Virtela Technology Services Inc., a Denver-based managed and cloud network services company. The deal is valued at around $525 million. www.virtela.net

NTT Communications Corp. (Tokyo: 9432) has agreed to acquire an 80% stake in RagingWire, a Sacramento, Calif.-based provider of data center and managed IT services, for $350 million.www.ragingwire.com

Orrick Herrington & Sutcliffe and Pillsbury Winthrop Shaw Pittman are in advanced talks to merge, according to the NY Times. A combination would create one of the nation’s 10 largest law firms with approximately 1,700 attorneys.

Alrosa, a Russian state-owned diamond mining company, raised around $1.3 billion in a public floatation. www.alrosa.ru

GlycoMimetics, a Gaithersburg, Md.-based developer of glycobiology-based therapies, has set its IPO terms to 4 million shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $218 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol GLYC, with Jefferies and Barclays serving as lead underwriters. It has raised over $60 million in VC funding from firms like New Enterprise Associates (75.2% pre-IPO stake), Genzyme Ventures (11.6%), The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures. www.glycomimetics.com

Karyopharm Therapeutics, a Natick, MA-based developer of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has set its IPO terms to 5.67 million shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $414 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol KPTI, with BoA Merrill Lynch and Leerink Swann serving as lead underwriters. It has raised over $70 million in VC funding from firms like Foresite Capital (9.42% pre-IPO stake), Delphi Ventures (8.17%) and New Leaf Venture Partners.www.karyopharm.com

LGI Homes, a builder of entry-level homes in Texas, Arizona, Florida and Georgia, has set its IPO terms to 9 million shares being offered at between $13 and $15 per share. It would have an initial market cap of approximately $272 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol LGIH, with Deutsche Bank, JMP Securities and J.P. Morgan serving as lead underwriters. www.workforlgihomes.com

Norcraft Companies Inc., an Egan, Minn.-based maker of kitchen and bathroom cabinetry, has set its IPO terms to 5.88 million shares being offered at between $16 and $18 per share. It would have an initial market cap of approximately $311 million, were it to price in the middle of its range. The company plans to trade on the NYSE under ticker symbol NCFT, with Citigroup and UBS serving as lead underwriters. It reports $3.5 million in net income on nearly $168 million in revenue for the first half of 2013. Shareholders include KarpReilly and Trimaran Capital Partners. www.norcraftcompanies.com